ARCHIVES

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Weldon Gage named CFO at MD Anderson Cancer Center

December 12, 2014

Congress Hasn’t Completed Action Yet On Major Health Bills; Reauthorization Fight In 1988-89

July 17, 1987

Oncology Nurses Urged To Help Set Agenda For Health Care Reform

May 29, 1992

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007

Analyzing Tumor Tissue In Clinical Trials Can Improve Outcomes, RTOG Trial Finds

May 27, 2011

It’s Official : PRI Wins Massive FCRF Contract ; DMS Keeps Library, Lands Computer Servicea

September 18, 1987